<doc>
  <docmeta id="113hr1220ih">
    <bill congress="113" type="hr" number="1220" version="ih"/>
    <revision size="4152" annotations="0" id="6" commit-time="2013-04-05T15:21:05+00:00" committer="favila" doc="113hr1220ih/6.xml" status="complete">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HDDE8AD359E264E17AF94D2D8F5BCA6C9" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 HR 1220 IH: Asthma Inhalers Relief Act of 2013</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2013-03-15</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">I</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>H. R. 1220</legis-num>
		<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action>
			<action-date date="20130315">March 15, 2013</action-date>
			<action-desc>
        <sponsor name-id="B001248">Mr. Burgess</sponsor> (for
			 himself, <cosponsor name-id="D000355">Mr. Dingell</cosponsor>, and
			 <cosponsor name-id="M001142">Mr. Matheson</cosponsor>) introduced the following
			 bill; which was referred to the <committee-name committee-id="HIF00">Committee
			 on Energy and Commerce</committee-name>
      </action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To direct the Administrator of the Environmental
		  Protection Agency to allow for the distribution, sale, and consumption in the
		  United States of remaining inventories of over-the-counter CFC epinephrine
		  inhalers.</official-title>
	</form>
	<legis-body id="H75368B46CAE748E59766D1EB5DB43708" style="OLC">
		<section id="HD48480C4CD1E4D6EAC8BAE0C29239C07" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the
			 <quote>
          <short-title>Asthma Inhalers Relief Act of
			 2013</short-title>
        </quote>.</text>
		</section>
    <section id="HBE0800C1DD4C4CA688F58D0180F2994B">
      <enum>2.</enum>
      <header>Distribution,
			 sale, and consumption of remaining inventories of over-the-counter CFC
			 epinephrine inhalers</header>
			<subsection id="HB19D5EC0206445CA8E2153776B73F9B0">
        <enum>(a)</enum>
        <header>In
			 general</header>
        <text display-inline="yes-display-inline">The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="6800">Administrator of
			 the Environmental Protection Agency</cato:entity-ref>—</text>
				<paragraph id="H7333524E44364EE4BC4D7D49B2FE040B">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">shall allow for the distribution, sale, and
			 consumption in the United States of remaining inventories of CFC epinephrine
			 inhalers manufactured pursuant to the exception for medical devices under
			 <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Clean Air Act/s:604/ss:d/p:2">section 604(d)(2) of the Clean Air Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/7671c">
                <cato:entity-ref entity-type="uscode" value="usc/42/7671c/d/2">42 U.S.C. 7671c(d)(2)</cato:entity-ref>
              </external-xref>)</cato:entity>;</text>
				</paragraph>
        <paragraph id="H65B4F7FAA22E4BFEB18BFED40EA2D2A9">
          <enum>(2)</enum>
          <text display-inline="yes-display-inline">shall not take any enforcement action or
			 otherwise seek to restrict the distribution, sale, or consumption of such
			 inhalers on the basis of any Federal law implementing the Montreal Protocol;
			 and</text>
				</paragraph>
        <paragraph id="HC5E5817AED194AA7BFDB33B17568BC9B">
          <enum>(3)</enum>
          <text>shall, in response
			 to any request of any distributor or seller of such inhalers, including any
			 such request pending on the date of the enactment of this Act, issue a No
			 Action Assurance Letter to the requesting party stating that the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="6800">Environmental
			 Protection Agency</cato:entity-ref> will not initiate an enforcement action relating to the
			 distribution or sale of any such inhaler occurring prior to August 1,
			 2013.</text>
				</paragraph>
      </subsection>
      <subsection id="H3017DC8D05E14FBC884CC791E828F2D9">
        <enum>(b)</enum>
        <header>Rule of
			 construction</header>
        <text display-inline="yes-display-inline">Nothing in this
			 Act shall be construed to limit or otherwise affect the authority of the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food
			 and Drug Administration</cato:entity-ref> under the <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<cato:entity-ref entity-type="uscode" value="usc/21/301/etseq">21
			 U.S.C. 301 et seq.</cato:entity-ref>)</cato:entity> to ensure the safety and effectiveness of CFC epinephrine
			 inhalers to be distributed, sold, or consumed pursuant to this Act.</text>
			</subsection>
      <subsection id="H9E21F4305A184B80BD0C031FDF8EDCE3">
        <enum>(c)</enum>
        <header>Definitions</header>
        <text>In
			 this Act:</text>
				<paragraph id="H406B4569BB1048EB8041E54DB37C1F6C">
          <enum>(1)</enum>
          <text display-inline="yes-display-inline">The term <term>CFC epinephrine
			 inhaler</term> means any epinephrine inhaler containing
			 chlo­ro­fluo­ro­car­bons that was manufactured and classified as
			 over-the-counter before January 1, 2012.</text>
				</paragraph>
        <paragraph id="H11FF120E449D4B0E85A5370FA0920D4A">
          <enum>(2)</enum>
          <text>The phrase
			 <term>Federal law implementing the Montreal Protocol</term>—</text>
					<subparagraph id="H5E1D3A4D5E4F4586A6F2A4FF0DB021DD">
            <enum>(A)</enum>
            <text display-inline="yes-display-inline">means any provision of <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
                <cato:entity-ref entity-type="act" value="Clean Air Act/t:VI">title VI of the
			 Clean Air Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/7671">42 U.S.C. 7671 et seq.</external-xref>)</cato:entity> or other Federal law implementing the
			 Montreal Protocol; and</text>
					</subparagraph>
          <subparagraph id="H81F0E7C4DC9B4B20BC0366BC1B96F25A">
            <enum>(B)</enum>
            <text display-inline="yes-display-inline">includes the final rule published by the
			 <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> entitled <term>Use of Ozone-Depleting Substances;
			 Removal of Essential-Use Designation (Epinephrine)</term> published in the
			 Federal Register at 73 Federal Register 69532 (November 19, 2008).</text>
					</subparagraph>
        </paragraph>
        <paragraph id="H40E3D620CF334981BF5502E95C6238D8">
          <enum>(3)</enum>
          <text>The term
			 <term>Montreal Protocol</term> has the meaning given such term in <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Clean Air Act/s:601">section 601
			 of the Clean Air Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/42/7671">42 U.S.C. 7671</external-xref>)</cato:entity>.</text>
				</paragraph>
        <paragraph id="H35CBD98D75B24BCA9D12C4FD2DBC1623">
          <enum>(4)</enum>
          <text>The term
			 <term>over-the-counter</term> means not subject to <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
              <cato:entity-ref entity-type="act" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1">section 503(b)(1) of the
			 Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/353">
                <cato:entity-ref entity-type="uscode" value="usc/21/353/b/1">21 U.S.C. 353(b)(1)</cato:entity-ref>
              </external-xref>)</cato:entity> or otherwise
			 required pursuant to Federal law to be dispensed only upon issuance of a
			 prescription.</text>
				</paragraph>
      </subsection>
      <subsection id="H0C159E5ED07140DB84EC44EF2F6DED8D">
        <enum>(d)</enum>
        <header>Sunset</header>
        <text>This
			 section ceases to be effective August 1, 2013.</text>
			</subsection>
    </section>
  </legis-body>
</bill>
</doc>